About us
Reimagining Cancer Treatment Through the Power of Immunotherapy
At DVLR Therapeutics, we’re not just developing treatments, we’re building a future where cancer is no longer a life sentence. We specialize in viral immunotherapies that work with your body’s immune system to target and destroy tumors from within.
Our lead platforms, CAN-2409 and CAN-3110, are designed to fight solid tumors and glioblastoma with precision and hope. We’re a passionate team of scientists, clinicians, and caregivers united by one mission:
To bring powerful, science-backed cancer therapies to the people who need them most.
🔹 Headquartered in Innovation
🔹 Backed by Decades of Research
🔹 Driven by Patient-Centered Values
1.Discovery & Innovation
We begin by identifying viral platforms that stimulate the immune system inside tumors. Our R&D team collaborates with top institutions to ensure our science is always at the cutting edge.
2. Clinical Precision
Through rigorous clinical trials, we test and refine therapies like CAN-2409 and CAN-3110—ensuring safety, efficacy, and real-world readiness for those facing complex cancers.
Open Position
DATA ENTRY CLERK (REMOTE)
Contact us
Your Health, Your Time. Let’s Make It Count.
Book your appointment today and take the first step towards a healthier, brighter future with care you can trust and a team that truly listens.